SPN-812

viloxazine · Supernus Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for SPN-812, covering 2019-09-18 to 2026-07-15. Get the full timeline:

Most recent: Clinical Trial Update: Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) [Phase 3]

See pricing